6:35Long-form

The Phase III STARGLO trial: Glofit-GemOx versus R-GemOx for R/R DLBCL

United KingdomPublished July 9, 2024

Views 1.13K  |  Likes 7  |  Comments 0
Views#16,998,060Global
Views#435,614United Kingdom

Channel

VJHemOnc – Video Journal of Hematology & HemOncVJHemOnc – Video Journal of Hematology & HemOnc
18.3K subs•18.5K videos•Feb 2015

Based on an estimated $0.7–$2 CPM, this video's 1.13K views translate to an estimated $1 – $2 in lifetime ad revenue.

Revenue estimate

Based on an estimated $0.7–$2CPM (revenue per 1,000 views) — a rough public estimate, not actual creator earnings, which depend on ad rates, audience geography, and monetization settings YouTube doesn't expose publicly.

Total (all-time)$1 – $2